Ziopharm Oncology reported $-11051000 in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
AstraZeneca AZN:LN -292000000 1.38B
Corcept Therapeutics CORT:US $ 36.66M 0.43M
Eleven Biotherapeutics EBIO:US -835000 9.79M
Immunogen IMGN:US $ -22.85M 11.7M
Intrexon XON:US $ -25.47M 9.8M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Novartis NOVN:VX 2.56B 671M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Tg Therapeutics TGTX:US $ -92.95M 7.82M
Verastem VSTM:US $ -16.98M 2.13M